Suven Life Sciences Quarterly Results

Charts

YoY Net Sales (Quarterly)

Operating Margin

EPS Growth

POSITIVES

Revenue showed a decline but was higher in the latest quarter compared to previous quarters, indicating potential stabilization.
Operating losses have narrowed in the latest quarter, reflecting improved operational efficiency.
Other income has increased consistently, contributing positively to overall financials.

NEGATIVES

The net profit continues to remain negative, worsening in the last quarter, indicating ongoing financial distress.
Significant fluctuations in revenue highlight instability in sales performance.
The EPS has deteriorated over the quarters, raising concerns about profitability moving forward.

Field	Sep 23	Dec 23	Mar 24	Jun 24	Sep 24	Dec 24	Mar 25	Jun 25
Revenue	3.06	2.45	2.39	1.01	2.57	1.61	1.47	1.87
Expenses	28.34	50.28	34.21	33.05	56.25	42.36	46.63	53.98
Operating Profit	-25.28	-47.83	-31.83	-32.05	-53.68	-40.75	-45.17	-52.12
Other Income	5.14	6.07	4.28	4.01	4.04	1.63	1.22	0.60
Interest	0.04	0.03	0.03	0.02	0.02	0.01	0	0
Depreciation	1.73	1.60	1.51	1.49	1.46	1.53	1.35	1.37
Profit Before Tax	-12.68	-41.77	-27.54	-28.04	-49.64	-39.12	-43.94	-51.52
Tax	0	0	-1	0	0	0	0	0
Net Profit	-12.68	-41.77	-26.54	-28.04	-49.64	-39.12	-43.95	-51.52
Eps in Rs	-0.58	-1.92	-1.22	-1.29	-2.27	-1.79	-2.02	-2.36